Patents by Inventor Jeremy Marks

Jeremy Marks has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12221441
    Abstract: The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.
    Type: Grant
    Filed: August 16, 2023
    Date of Patent: February 11, 2025
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Nikolaos Papaioannou, Jeremy Mark Travins, Sarah Jocelyn Fink, John Mark Ellard, Alastair Rae
  • Patent number: 12184591
    Abstract: Disclosed are systems and methods for conducting an open conversation user interface and more particularly, to a channel-agnostic user interface experience which can utilize automated background intelligence to simplify the exchange between a software system or member service representative (MSR) and a member, and avoids the need for web-based free form inputs.
    Type: Grant
    Filed: January 25, 2024
    Date of Patent: December 31, 2024
    Assignee: UIPCO, LLC
    Inventors: Ian Smith, Jeremy Mark Fisher, Heather Hernandez
  • Publication number: 20240425478
    Abstract: Described here are compounds of Formula (I) and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising same, and their use and preparation.
    Type: Application
    Filed: October 4, 2022
    Publication date: December 26, 2024
    Inventors: Jessica Marie GRANDNER, Kevin M. JOHNSON, Steven MAGNUSON, Jeremy Mark MURRAY, Brendan T. PARR, Vishal A. VERMA, Yong WANG, Mingshuo ZENG, Melissa A. ASHLEY
  • Publication number: 20240382482
    Abstract: The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.
    Type: Application
    Filed: March 16, 2022
    Publication date: November 21, 2024
    Inventors: Nikolaos PAPAIOANNOU, Jeremy Mark TRAVINS, Sarah Jocelyn FINK, John Mark ELLARD, Alastair RAE, Jonathan Andrew SPENCER
  • Patent number: 12065448
    Abstract: The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.
    Type: Grant
    Filed: June 3, 2022
    Date of Patent: August 20, 2024
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Nikolaos Papaioannou, Jeremy Mark Travins, Sarah Jocelyn Fink, John Mark Ellard, Alastair Rae
  • Publication number: 20240226106
    Abstract: The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.
    Type: Application
    Filed: March 16, 2022
    Publication date: July 11, 2024
    Inventors: Nikolaos PAPAIOANNOU, Jeremy Mark TRAVINS, Sarah Jocelyn FINK, John Mark ELLARD, Alastair RAE
  • Publication number: 20240228488
    Abstract: The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.
    Type: Application
    Filed: March 16, 2022
    Publication date: July 11, 2024
    Inventors: Nikolaos PAPAIOANNOU, Jeremy Mark TRAVINS, Sarah Jocelyn FINK, John Mark ELLARD, Alastair RAE, Jonathan Andrew SPENCER, Stuart Shane RANKIN, Robert Staurt Laurie CHAPMAN
  • Publication number: 20240199613
    Abstract: The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.
    Type: Application
    Filed: March 16, 2022
    Publication date: June 20, 2024
    Inventors: Nikolaos PAPAIOANNOU, Jeremy Mark TRAVINS, Sarah Jocelyn FINK, John Mark ELLARD, Alastair RAE, Stuart Shane RANKIN, Robert Staurt Laurie CHAPMAN
  • Publication number: 20240199612
    Abstract: The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.
    Type: Application
    Filed: March 16, 2022
    Publication date: June 20, 2024
    Inventors: Nikolaos PAPAIOANNOU, Jeremy Mark TRAVINS, Sarah Jocelyn FINK, John Mark ELLARD, Alastair RAE
  • Patent number: 11916852
    Abstract: Disclosed are systems and methods for conducting an open conversation user interface and more particularly, to a channel-agnostic user interface experience which can utilize automated background intelligence to simplify the exchange between a software system or member service representative (MSR) and a member, and avoids the need for web-based free form inputs.
    Type: Grant
    Filed: May 6, 2022
    Date of Patent: February 27, 2024
    Assignee: UIPCO, LLC
    Inventors: Ian Smith, Jeremy Mark Fisher, Heather Hernandez
  • Publication number: 20230391773
    Abstract: The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.
    Type: Application
    Filed: August 16, 2023
    Publication date: December 7, 2023
    Inventors: Nikolaos Papaioannou, Jeremy Mark Travins, Sarah Jocelyn Fink, John Mark Ellard, Alastair Rae
  • Patent number: 11787796
    Abstract: The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.
    Type: Grant
    Filed: September 17, 2020
    Date of Patent: October 17, 2023
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Nikolaos Papaioannou, Jeremy Mark Travins, Sarah Jocelyn Fink, John Mark Ellard, Alastair Rae
  • Publication number: 20230078513
    Abstract: The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.
    Type: Application
    Filed: April 20, 2022
    Publication date: March 16, 2023
    Inventors: Nikolaos Papaioannou, Sarah Jocelyn Fink, Thomas Allen Miller, Gerald Wayne Shipps, JR., Jeremy Mark Travins, David Edward Ehmann, Alastair Rae, John Mark Ellard
  • Patent number: 11504055
    Abstract: The following disclosure discusses systems and methods of detecting and analyzing cutaneous conditions. According to one embodiment, a 2D image of the cutaneous condition and a set of 3D point clouds associated with the 2D image are captured using an image capturing device. The 2D image and the set of 3D point clouds are sent to a computing device. The computing device generates a 3D surface according to the set of 3D point clouds. Subsequently, the computing device receives a depth map for the 2D image based upon the 3D surface from another computing device such that the depth map comprises depth data for each pixel of the 2D image. The cutaneous condition may then be measured and analyzed based upon the depth map using the computing device.
    Type: Grant
    Filed: August 15, 2018
    Date of Patent: November 22, 2022
    Assignee: IKO PTE. LTD.
    Inventors: Jeremy Mark Massey, Syed Haroon Alam, Paul Lorenz Bigliardi, Mei Bigliardi-Qi
  • Publication number: 20220339470
    Abstract: The present technology relates to open respirator devices having sensors for measuring breath biometrics. For example, a respirator device (100) can include a mask component (102) that fits at least partially over a user's face and forms a gap (112) between a periphery of the mask component and the user's face, thereby forming a breathing chamber (108) between the mask portion and the user's face. A fan unit can provide air from the external environment to the breathing chamber for the user to inhale. In some embodiments, the air may be filtered before entering the breathing chamber and the fans may provide a positive pressure seal between across the gap. One or more sensors can be coupled to the mask component for measuring one or more metrics associated with the user's breath.
    Type: Application
    Filed: September 11, 2020
    Publication date: October 27, 2022
    Inventors: Daniel Bowden, Ilya Rozhdestvensky, Jeremy Mark Mauger, Hamish Jock Graham
  • Publication number: 20220298176
    Abstract: The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.
    Type: Application
    Filed: June 3, 2022
    Publication date: September 22, 2022
    Inventors: Nikolaos Papaioannou, Jeremy Mark Travins, Sarah Jocelyn Fink, John Mark Ellard, Alastair Rae
  • Patent number: 11370803
    Abstract: The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.
    Type: Grant
    Filed: September 17, 2020
    Date of Patent: June 28, 2022
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Nikolaos Papaioannou, Jeremy Mark Travins, Sarah Jocelyn Fink, John Mark Ellard, Alastair Rae
  • Patent number: 11352356
    Abstract: The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.
    Type: Grant
    Filed: June 22, 2020
    Date of Patent: June 7, 2022
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Nikolaos Papaioannou, Sarah Jocelyn Fink, Thomas Allen Miller, Gerald Wayne Shipps, Jr., Jeremy Mark Travins, David Edward Ehmann, Alastair Rae, John Mark Ellard
  • Patent number: 11349785
    Abstract: Disclosed are systems and methods for conducting an open conversation user interface and more particularly, to a channel-agnostic user interface experience which can utilize automated background intelligence to simplify the exchange between a software system or member service representative (MSR) and a member, and avoids the need for web-based free form inputs.
    Type: Grant
    Filed: January 25, 2021
    Date of Patent: May 31, 2022
    Assignee: UIPCO, LLC
    Inventors: Ian Smith, Jeremy Mark Fisher, Heather Hernandez
  • Publication number: 20220143344
    Abstract: The present technology relates to respirator devices including source control features. In some embodiments, a source control mask device can include a shield that substantially covers the mouth and nose of a user and a mechanism that can actively extract air as it is exhaled by the user. The extracted exhaled air can then be sanitized before the mask device discharges it into the atmosphere. The mask device may selectively form a seal to the user's face dependent on air flow conditions.
    Type: Application
    Filed: August 19, 2021
    Publication date: May 12, 2022
    Inventor: Jeremy Mark Mauger